N-acetyl Cysteine and Patients with Non-alcoholic Fatty Liver Disease

Effect of N-acetyl Cysteine on Markers of Oxidative Stress and Insulin Resistance in Patients with Non-alcoholic Fatty Liver Disease

Effect of N-acetyl cysteine on markers of oxidative stress and insulin resistance in patients with Non-alcoholic fatty liver disease

Inclusion Criteria:

• Males or females aged 18-60 years diagnosed with NAFLD

Exclusion Criteria:

• History of alcohol consumption, drug addiction or the use of medications known to precipitate steatohepatitis.
• Patients with schistosomiasis, active hepatitis B or C, autoimmune and diabetes mellitus.
• current Consumption of any antioxidant supplements and hepatotoxic drug.
• Pregnancy or lactation or expecting to get pregnant during the study.
• Medical, psychological, or pharmacological factors interfering with the collection or interpretation of study data.
• Active Cancer patients.
• Anyone having hypersensitivity to N-acetylcysteine.
• Anyone already taking N-acetylcysteine.